Ohio State University

Gatekeeper Innovation Applauds OH for Drug Diversion Program in OH State Bill 110

Thursday, September 23, 2021 - 6:39pm

says Kevin Kane, CEO of Gatekeeper Innovation Inc. " Gatekeeper's Rx Locking Cap is available in Walgreens and CVS pharmacies."

Key Points: 
  • says Kevin Kane, CEO of Gatekeeper Innovation Inc. " Gatekeeper's Rx Locking Cap is available in Walgreens and CVS pharmacies."
  • About Gatekeeper Innovation Inc:Gatekeeper Innovation Inc. is a Sacramento-based company offering tamper-evident and abuse-deterrent technology while supporting medication adherence.
  • Gatekeeper Innovation's mission is to provide options for securing prescription medications to help prevent Diversion and Substance Use Disorder.
  • To learn more about Gatekeeper's diversion products, visit: gatekeeperinnovation.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/gatekeeper-innovation-applauds-...

RECUR Announces Partnerships with Louisiana State University, Syracuse University and BrandR Group for new Collegiate NFT Marketplace, NFTU

Thursday, September 23, 2021 - 3:00pm

A week after RECUR announced plans to launch the official NFT collegiate destination - NFTU.com - RECUR announced today that Syracuse University and Louisiana State University have joined its NFTU program to bring in their college sports moments and marks.

Key Points: 
  • A week after RECUR announced plans to launch the official NFT collegiate destination - NFTU.com - RECUR announced today that Syracuse University and Louisiana State University have joined its NFTU program to bring in their college sports moments and marks.
  • View the full release here: https://www.businesswire.com/news/home/20210923005318/en/
    RECUR Announces Partnerships with Louisiana State University, Syracuse University and BrandR Group for new Collegiate NFT Marketplace, NFTU (Photo: Business Wire)
    LSU and Syracuse are of the first group of colleges entering into the NFT arena meaningfully.
  • The relationship with BrandR group allows us to create new promotional opportunities for student athletes who can now marry NFTs using university IP with athletes NIL.
  • The Brandr Group is a leader in the group licensing space and immediately elevates opportunities for current and former student athletes.

Rare Adverse Effects Continue to Fuel Covid-19 Vaccine Hesitancy, Despite Safety Breakthroughs

Thursday, September 23, 2021 - 2:30pm

Albeit rare, life-threatening side effects, such as abnormal blood clotting or myocarditis can be the result from either recombinant full-length or partial Spike proteinwhich are found in currently available vaccines.

Key Points: 
  • Albeit rare, life-threatening side effects, such as abnormal blood clotting or myocarditis can be the result from either recombinant full-length or partial Spike proteinwhich are found in currently available vaccines.
  • These toxicities may be caused by unwanted binding of the vaccine spike protein to ACE2 receptors in the heart or platelet factor 4.
  • Biovaxysbelieves that the haptenized spike protein has much diminished ability to bind to ACE2, which would result in much diminished vaccine toxicity.
  • "The results could provide evidence that our vaccine has lowered potential for some of the observed serious vaccine side effects."

Rare Adverse Effects Continue to Fuel Covid-19 Vaccine Hesitancy, Despite Safety Breakthroughs

Thursday, September 23, 2021 - 2:30pm

VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- USA News Group  -  Despite the approval for the Comirnaty vaccine from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) by the FDA back in August, vaccine hesitancy in the USA persists and is unlikely to disappear. Now with what PFE/BNTX are calling encouraging results for their Covid-19 vaccine trial on kids in hand, it's expected that parents are going to be even more hesitant to jab their own children. Reports of heart inflammation are adding fuel to the fire, spurning closer studies into myocarditis risk taking place inIsrael and the USA, and Canada particularly with mRNA vaccines such as those from Pfizer, BioNTech and Moderna, Inc. (NASDAQ:MRNA), while earlier this year multiple European countries suspended the use of AstraZeneca PLC (NASDAQ:AZN) over worries about blood clots. While these manufacturers are standing by their safety and efficacy, a new study on the hapten-modified spike protein used in the BVX-0320 SARS-CoV-2 vaccine from BioVaxys Technology Corp. (CSE:BIOV) (OTCQB:BVAXF) is giving hope to another method that could potentially mitigate some of these abnormal life-threatening side effects.

Key Points: 
  • Albeit rare, life-threatening side effects, such as abnormal blood clotting or myocarditis can be the result from either recombinant full-length or partial Spike proteinwhich are found in currently available vaccines.
  • These toxicities may be caused by unwanted binding of the vaccine spike protein to ACE2 receptors in the heart or platelet factor 4.
  • Biovaxysbelieves that the haptenized spike protein has much diminished ability to bind to ACE2, which would result in much diminished vaccine toxicity.
  • "The results could provide evidence that our vaccine has lowered potential for some of the observed serious vaccine side effects."

Roses Natural Offers a Safe Solution for Irritated Skin

Thursday, September 23, 2021 - 1:38pm

He would use natural, simple, and effective ingredients that were safe for everyone to use.

Key Points: 
  • He would use natural, simple, and effective ingredients that were safe for everyone to use.
  • She summarizes the genesis of her company by saying that, "Roses Natural was created based on my skin condition," adding that, "The idea was to create plant-based products that will not irritate my skin but also be safe for the environment."
  • In early 2021, the Roses Natural family officially started to grow when Kola Akinmuyiwa joined the company as a managing partner.
  • About Roses Natural: Roses Natural was created by Roseline Okoro and launched in 2018.

Plant-based Nutritional Supplement Brand PlantFuel Taps College Athletes in Newly Launched Partnership Program

Wednesday, September 22, 2021 - 3:00pm

MISSISSAUGA, ON, Sept. 22, 2021 /PRNewswire/ -- PlantFuel Life Inc. (CSE: FUEL) (OTC: BLLXF) (FSE: BR1B) ("PlantFuel" or the "Company"), the scientifically focused plant-based wellness company, today announced members of its official College Athlete Partnerships Program. Following the NCAA's recent rule change, college athletes are now allowed to profit from their names, images and likeness (NIL), and PlantFuel is tapping into a diverse group of student athletes from a range of athletic talents. 

Key Points: 
  • MISSISSAUGA, ON, Sept. 22, 2021 /PRNewswire/ -- PlantFuel Life Inc. (CSE: FUEL) (OTC: BLLXF) (FSE: BR1B) ("PlantFuel" or the "Company"), the scientifically focused plant-based wellness company, today announced members of its official College Athlete Partnerships Program.
  • Following the NCAA's recent rule change, college athletes are now allowed to profit from their names, images and likeness (NIL), and PlantFuel is tapping into a diverse group of student athletes from a range of athletic talents.
  • "This is an entirely new frontier for brands to connect with college athletes," said PlantFuel Founder, Brad Pyatt.
  • Through PlantFuel's new program, athletes will promote the brand through social media activities, personal appearances, and content on the brand's website.

Rave Mobile Safety Unveils the Enhanced Rave Platform to Unify the Critical Response and Collaboration Experience

Tuesday, September 21, 2021 - 1:30pm

Rave Mobile Safety (Rave), the leading provider of the critical communication and collaboration platform over 8,000 customers count on when it matters most , today announced the new Rave Platform experience, which centralizes critical response and collaboration functions in a single unified interface to streamline communication, coordination and task management during time-critical events.

Key Points: 
  • Rave Mobile Safety (Rave), the leading provider of the critical communication and collaboration platform over 8,000 customers count on when it matters most , today announced the new Rave Platform experience, which centralizes critical response and collaboration functions in a single unified interface to streamline communication, coordination and task management during time-critical events.
  • As the industrys only comprehensive safety platform, Rave enables those tasked with protecting their communities with the ability to address the challenges of critical communications, incident collaboration, safety and protection and 9-1-1 response holistically.
  • The platform eliminates the need for separate interfaces for different solutions, and improves the visibility of capabilities across Raves critical communication and collaboration tools.
  • Rave Mobile Safety is the leading provider of critical communication and collaboration technology used to save lives, manage crisis incidents and increase resiliency.

NAVC To Host First Annual Global Veterinary Nurse Virtual Summit October 16 - 17

Thursday, September 16, 2021 - 1:55pm

ORLANDO, Sept. 16, 2021 /PRNewswire/ --The North American Veterinary Community (NAVC) today announced the launch of Level Up: Veterinary Nurses & Technicians, a new virtual summit it will host annually in October during Veterinary Technician Appreciation Week.

Key Points: 
  • ORLANDO, Sept. 16, 2021 /PRNewswire/ --The North American Veterinary Community (NAVC) today announced the launch of Level Up: Veterinary Nurses & Technicians, a new virtual summit it will host annually in October during Veterinary Technician Appreciation Week.
  • The veterinary nurse summit marks the first of the new Level Up series of virtual learning events that the NAVC will host under its Virtual XP learning umbrella.
  • The NAVC's veterinary nurse virtual summit is particularly important and timely given the surge in pet ownership and their owner's desire to provide the best veterinary medical care possible.
  • Level Up: Veterinary Nurses & Techniciansprovides veterinary nurses and technicians with a high-quality, complimentary virtual CE event in association with Veterinary Technician Appreciation Week.

Ohio State University Wexner Medical Center Receives Ohio's First Hyperfine Portable MRI Systems to Speed Scanning and Diagnosis for Urgent Brain Injuries

Thursday, September 16, 2021 - 12:00pm

The Ohio State Wexner Medical Center is the first in the state of Ohio, and one of the first in the country, to offer this technology to its patients.

Key Points: 
  • The Ohio State Wexner Medical Center is the first in the state of Ohio, and one of the first in the country, to offer this technology to its patients.
  • "As one of the leading comprehensive stroke centers in the country, Ohio State Wexner Medical Center has always been on the cutting edge of diagnosing and treating critical brain injuries," said Rob Korn, senior vice president of sales for Hyperfine.
  • "We're excited to provide Ohio State with the world's first portable MRI system which gives clinicians critical decision-making capabilities across a variety of clinical settings."
  • Hyperfine designed the Swoop Portable MR Imaging System to overcome patient transport and dedicated room requirements associated with fixed conventional MRI systems.

New Journal Article on the Challenges and Management of Sarcoidosis Supported by Foundation for Sarcoidosis Research

Wednesday, September 15, 2021 - 5:01pm

"Delayed diagnosis and lack of understanding of sarcoidosis are significant barriers to care for those living with sarcoidosis," says Mary McGowan, CEO for the Foundation for Sarcoidosis Research.

Key Points: 
  • "Delayed diagnosis and lack of understanding of sarcoidosis are significant barriers to care for those living with sarcoidosis," says Mary McGowan, CEO for the Foundation for Sarcoidosis Research.
  • Challenges of Sarcoidosis and Its Management is the first sarcoidosis scientific article published in NEJM since 2007 and is now considered the new standard of sarcoidosis review.
  • Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.
  • Established in 2000, The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients.